Caitlin Raymond on ”The Plasma Chasers”
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared on LinkedIn:
”I wrote a new piece this week about something I hadn’t encountered until I became an attending: the “plasma chaser.”
It’s not in ASFA guidelines, not in textbooks, and not something I ever saw in residency or fellowship. But it came up twice in two days, and it made me pause and think about how we make replacement-fluid decisions after recent procedures — and how much of that work happens in the gray space where physiology, experience, and uncertainty meet.
What I found, digging into the peer-reviewed survey data, is striking:
- 8.9% of clinicians still use albumin-only replacement one day after major surgery, a number much higher than I was expecting.
- Clinicians are split about 50/50 on using albumin vs plasma for replacement fluid a day following a minor procedure.
- For a patient scenario with no bleeding risk, 5.3% of clinicians will still use plasma, also higher than I was expecting.
There’s a story in those numbers — about risk perception, about judgment, and about how small, experience-driven practices evolve when formal guidance is limited.
In my blog post, I tried to unpack this… not to prescribe a standard, but to explore how we think through these nuanced decisions and why certain rituals persist in medicine. And also where a rational, physiologic framework can help us cut through the uncertainty.
If you’re interested in the intersection of transfusion medicine, clinical reasoning, and the quiet rituals we inherit in practice, you can read the full piece here.
Would love to hear how others approach post-procedure TPE decisions in their practice — especially where your institution aligns with (or diverges from) the survey data.”

Stay updated with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy
